Non-neuronal ferroptosis in the central nervous system
Ferroptosis and Oxidative Stress · 2026
DOI: 10.70401/fos.2026.0030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ferroptosis and Oxidative Stress, 2026. Verfasst von Jack Winneberger und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Ferroptosis, a lipid peroxidation-driven form of regulated cell death, has emerged as a central mechanism in neurological disease. While most studies have focused on neuronal vulnerability, non-neuronal cells, including oligodendrocytes, astrocytes, microglia, brain endothelial cells, and central nervous system (CNS) infiltrating T cells, play equally critical roles in shaping disease progression. These cell types regulate iron homeostasis, lipid metabolism, antioxidant defenses, and inflammatory signaling, thereby establishing the microenvironmental conditions that determine ferroptotic susceptibility within the CNS. Accumulating evidence demonstrates lipid peroxidation and ferroptosis-related signaling in demyelinating disorders, ischemic injury, small vessel disease, Alzheimer’s disease, Parkinson’s disease, and spinal cord injury. However, the contribution of non-neuronal cells to ferroptotic stress and execution remains comparatively underexplored. In this review, we synthesize emerging data highlighting cell type-specific dependencies on glutathione peroxidase 4 (GPX4), solute carrier family 7 member 11 (SLC7A11), ferroptosis suppressor protein 1 (FSP1), nuclear factor erythroid 2-related factor 2 (NRF2), peroxiredoxin (PRDX), thioredoxin (TRX), iron-handling proteins, and lipid remodeling pathways, and discuss how these regulatory networks differ across CNS-resident and CNS infiltrating T cells. We propose that ferroptosis in neurological disease is not solely a neuron-autonomous event, but a tissue-level process orchestrated by non-neuronal cells with distinct metabolic and immunological programs. Understanding these cell type-specific vulnerabilities and regulatory mechanisms will be essential for the development of targeted therapeutic strategies aimed at modulating ferroptotic stress in neuroinflammatory and neurodegenerative disorders.
Zitieren
APA
Winneberger, J., Raich, L., Potthast, T., & Woo, M. S. (2026). Non-neuronal ferroptosis in the central nervous system. Ferroptosis and Oxidative Stress. https://doi.org/10.70401/fos.2026.0030
Vancouver
Winneberger J, Raich L, Potthast T, Woo MS. Non-neuronal ferroptosis in the central nervous system. Ferroptosis and Oxidative Stress. 2026. doi:10.70401/fos.2026.0030
BibTeX
@article{Winneberger2026,
author = {Winneberger, Jack and Raich, Lukas and Potthast, Tammo and Woo, Marcel S.},
title = {Non-neuronal ferroptosis in the central nervous system},
journal = {Ferroptosis and Oxidative Stress},
year = {2026},
doi = {10.70401/fos.2026.0030}
}
EUVIMED